Hydrophobic Ligand Entry and Exit Pathways of the CB1 Cannabinoid Receptor

被引:21
|
作者
Jakowiecki, Jakub [1 ]
Filipek, Slawomir [1 ]
机构
[1] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Ul Pasteura 1, PL-02093 Warsaw, Poland
关键词
FUNCTIONAL RESIDUES; CRYSTAL-STRUCTURE; BINDING; CHARMM; RECOGNITION; PREDICTION; GUI;
D O I
10.1021/acs.jcim.6b00499
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
It has been reported that some hydrophobic ligands of G-protein-coupled receptors access the receptor's binding site from the membrane rather than from bulk water. In order to identify the most probable ligand entrance pathway into the CB1 receptor, we performed several, steered molecular dynamics (SMD) simulations of two CB1 agonists, THC and anandamide, pulling them from the receptor's binding site with constant velocity. The four main directions of ligand pulling were probed: between helices TM4 and TM5, between TM5 and TM6, between TM7 and TM1/TM2, and toward the bulk water. The smallest forces were measured during pulling between TM7 and TM1/TM2. We also performed Supervised molecular dynamics (SuMD) simulations for both anandamide and THC entering the CB1 receptor's binding site and found the same pathway as in the pulling simulations. The residues F174(2.61) and F177(2.64) (both on the TM2 helix) are involved in the gating mechanism and, by forming pi-pi. interactions with ligand molecules, facilitated the ligand orientation required for passage. Using SuMD we also found an alternative binding site for THC. The results of mutagenesis studies evidencing that residues F174(2.61) and F177(2.64) are important for CB1 ligand binding are in agreement with our observations.
引用
收藏
页码:2457 / 2466
页数:10
相关论文
共 50 条
  • [1] Molecular basis for ligand modulation of the cannabinoid CB1 receptor
    Ramesh, Karthik
    Rosenbaum, Daniel M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (14) : 3487 - 3495
  • [2] Ligand based structural studies of the CB1 cannabinoid receptor
    Picone, RP
    Fournier, DJ
    Makriyannis, A
    [J]. JOURNAL OF PEPTIDE RESEARCH, 2002, 60 (06): : 348 - 356
  • [3] Cannabinoid CB1 Receptor Antagonists
    Thomas, Brian F.
    [J]. DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
  • [4] The CB1 cannabinoid receptor in the brain
    Howlett, AC
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416
  • [5] CB1 cannabinoid receptor antagonists
    Barth, F
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 103 - 118
  • [6] CB1 cannabinoid receptor ligands
    Thakur, GA
    Nikas, SP
    Makriyannis, A
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (07) : 631 - 640
  • [7] The Cannabinoid CB1 Receptor in Schizophrenia
    Borgan, Faith
    Kokkinou, Michelle
    Howes, Oliver
    [J]. BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 646 - 659
  • [8] Ligand-specific homology modeling of human cannabinoid (CB1) receptor
    Ai, Rizi
    Chang, Chia-en A.
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2012, 38 : 155 - 164
  • [9] Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor
    Hudson, Brian D.
    Hebert, Terence E.
    Kelly, Melanie E. M.
    [J]. MOLECULAR PHARMACOLOGY, 2010, 77 (01) : 1 - 9
  • [10] Voltage dependence of the cannabinoid CB1 receptor
    Goldberger, Esty
    Tauber, Merav
    Ben-Chaim, Yair
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13